CytoSorbents (CTSO) Stock Price, Quote, News & History | Benzinga

CytoSorbents Corp (CTSO) Stock Price, Quote, News & History

CTSONASDAQ

Trade with Public

Trade with Public

$0.3600

0.00471.32%

At close: Aug 26, 5:00 PM EST

$0.3605

0.00050.14%

After Hours: Aug 25, 6:24 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$0.35

Close

$0.36

Volume / Avg.

26.28K / 154.94K

Day Range

$0.35 - $0.38

52 Wk Range

0.30 - 1.04

Market Cap

$22.65M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

3.73%

Days to Cover

29.87

Recent Cytosorbents Corp News

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth

CytoSorbents is progressing with U.S. FDA and Health Canada reviews for its DrugSorb-ATR device.

Lekha Gupta

Why CytoSorbents (CTSO) Stock Is Trading Higher

CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group.

Henry Khederian

Gold Moves Lower; US Crude Stocks Decline Last Week

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90. The S&P 500 also rose, gaining, 0.23% to 4,792.56.

Avi Kapoor

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.15M

Investing Cash Flow (TTM)

-275.00K

Financing Cash Flow (TTM)

2.48M

Free Cash Flow (TTM)

-9.58M

Capital Expenditure (TTM)

-436.00K

Net Change in Cash (TTM)

-6.94M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$47.64M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.61

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-80.56%

Earnings Yield % (FWD)

-61.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.01

Company Debt

Total Debt

$17.24M

LT Debt

$3.09M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$4.41M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.35

Close

$0.36

Volume / Avg.

26.28K / 154.94K

Day Range

$0.35 - $0.38

52 Wk Range

0.30 - 1.04

Market Cap

$22.65M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

3.73%

Days to Cover

29.87

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous pol...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy CytoSorbents (CTSO) stock?

A

You can purchase shares of CytoSorbents (NASDAQ:CTSO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CytoSorbents (CTSO) competitors?

A

Other companies in CytoSorbents’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for CytoSorbents (CTSO) stock?

A

CytoSorbents has a consensus price target of $5.55.

Q

What is the current price for CytoSorbents (CTSO)?

A

The stock price for CytoSorbents (NASDAQ: CTSO) is $0.3605 last updated August 25, 2026 at 6:24 PM EDT.

Q

Does CytoSorbents (CTSO) pay a dividend?

A

There are no upcoming dividends for CytoSorbents.

Q

When is CytoSorbents (NASDAQ:CTSO) reporting earnings?

A

CytoSorbents does not have any upcoming earnings scheduled.

Q

Is CytoSorbents (CTSO) going to split?

A

There is no upcoming split for CytoSorbents.

Q

What sector and industry does CytoSorbents (CTSO) operate in?

A

CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.